Sofinnova Partners is a venture capital firm specializing in life sciences and sustainability investments. The company provides capital and strategic support to start-ups, early-stage, and growth-stage companies in the biotech, medtech, and green tech sectors. With a focus on innovation and sustainability, Sofinnova Partners aims to support companies that have the potential to make a significant impact on health and the environment.

Sofinnova Partners

Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and Europe with approximately $3.7B in assets under management and committed capital as of 12/31/2023. 

Spark Therapeutics

Vera Therapeutics

Bolt Biotherapeutics

Coherus Biosciences

IVERIC bio

Enovix

Humanigen

Marinus Pharmaceuticals

Natera

Prothena

Aerovate Therapeutics

Akouos

Apellis Pharmaceuticals

Seagen

Seres Therapeutics

Athira Pharma

Gyroscope Therapeutics

immatics biotechnologies

Infovista

Invitae

Sofinnova Investments 

COM:SOFINNOVA

Sofinnova Partners